Dette gælder selv i tilfælde af dosisafbrydelse, med mindre patienten forpligter sig til absolut og vedvarende seksuel afholdenhed, som bekræftes hver måned.
Contraception Women of childbearing potential must use one effective method of contraception for 4 weeks before therapy, during therapy, and until 4 weeks after lenalidomide therapy and even in case of dose interruption unless the patient commits to absolute and continuous abstinence confirmed on a monthly basis.